Literature DB >> 4642573

The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.

C M McKean.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4642573     DOI: 10.1016/0006-8993(72)90653-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  61 in total

1.  Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.

Authors:  Benedikt Sundermann; Bettina Pfleiderer; Harald E Möller; Wolfram Schwindt; Josef Weglage; Jöran Lepsien; Reinhold Feldmann
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

2.  Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients.

Authors:  K Ullrich; J Weglage; C Oberwittler; M Pietsch; B Fünders; H von Eckardstein; J P Colombo
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

3.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

4.  A model for hyperphenylalaninaemia due to tetrahydrobiopterin deficiency.

Authors:  R G Cotton
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

5.  Abnormal amino acid metabolism and brain protein synthesis during neural development.

Authors:  J V Hughes; T C Johnson
Journal:  Neurochem Res       Date:  1978-08       Impact factor: 3.996

6.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  The effect of hyperphenylalaninaemia on glycine metabolism in developing rat brain.

Authors:  C E Isaacs; O Greengard
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

Review 8.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

9.  High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2015-11-26       Impact factor: 4.797

Review 10.  Large neutral amino acids in the treatment of PKU: from theory to practice.

Authors:  Francjan J van Spronsen; Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2010-10-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.